Chronic Renal Dysfunction as an Independent Risk Factor for the Development of Cardiovascular Disease
- 1 March 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 13 (2) , 98-107
- https://doi.org/10.1097/01.crd.0000132600.45876.d0
Abstract
Cardiac disease is the leading cause of death in patients having end-stage renal disease (ESRD). Patients with ESRD have a higher risk for developing coronary artery disease (CAD) than one would estimate from the presence of traditional risk factors such as hypertension, diabetes, hyperlipidemia, and cigarette smoking. Patients with milder forms of renal dysfunction who do not require dialysis also appear to have an increased risk for CAD. ESRD is associated with anemia, hyperhomocystinemia, increased calcium-phosphate product, hypoalbuminemia, increased troponin, increased markers of inflammation, increased oxidant stress, and decreased nitric oxide activity, factors that could contribute to increased CAD risk. Patients with ESRD require aggressive management of traditional risk factors for CAD, which include hypertension, hyperlipidemia, hyperhomocystinemia, and hypercoagulability. Milder forms of renal dysfunction could also be predictors of occult CAD and should be screened for in assessing cardiac risk in asymptomatic individuals.Keywords
This publication has 88 references indexed in Scilit:
- Renal insufficiency and mortality from acute coronary syndromesAmerican Heart Journal, 2004
- Acetylcysteine Reduces Plasma Homocysteine Concentration and Improves Pulse Pressure and Endothelial Function in Patients With End-Stage Renal FailureCirculation, 2004
- Impaired Renal Clearance Explains Elevated Troponin T Fragments in Hemodialysis PatientsCirculation, 2004
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseHypertension, 2003
- Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensivesJournal Of Hypertension, 2003
- Cardiac troponins in renal insufficiencyJournal of the American College of Cardiology, 2002
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseKidney International, 1996
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991